Edesa Biotech, Inc.Edesa Biotech, Inc.Edesa Biotech, Inc.

Edesa Biotech, Inc.

No trades
See on Supercharts
Market capitalization
‪14.11 M‬USD
−0.83USD
‪−8.37 M‬USD
‪2.34 M‬
Beta (1Y)
1.11

About Edesa Biotech, Inc.

CEO
Pardeep Nijhawan
Headquarters
Markham
Employees (FY)
16
Founded
2007
ISIN
CA27966L3065
FIGI
BBG000R0LC72
Edesa Biotech, Inc. is a biopharmaceutical company, which focuses on acquiring, developing, and commercializing clinical stage drugs for inflammatory and immune-related diseases. Its clinical studies include EB05 for Acute Respiratory Distress Syndrome (ARDS), EB07 for systemic sclerosis (SSc), EB01 for chronic Allergic Contact Dermatitis (ACD), EB02 for hemorrhoids, and EB06 for vitiligo. The company was founded by Pardeep Nijhawan on June 12, 2007 and is headquartered in Markham, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of EDSA is 4.45 USD — it has increased by 2.06% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Edesa Biotech, Inc. stocks are traded under the ticker EDSA.
Edesa Biotech, Inc. is going to release the next earnings report on May 10, 2024. Keep track of upcoming events with our Earnings Calendar.
EDSA stock is 5.41% volatile and has beta coefficient of 1.11. Check out the list of the most volatile stocks — is Edesa Biotech, Inc. there?
One year price forecast for Edesa Biotech, Inc. has a max estimate of 32.00 USD and a min estimate of 19.00 USD.
EDSA earnings for the last quarter are −0.57 USD per share, whereas the estimation was −0.70 USD resulting in a 18.96% surprise. The estimated earnings for the next quarter are −1.21 USD per share. See more details about Edesa Biotech, Inc. earnings.
Edesa Biotech, Inc. revenue for the last quarter amounts to ‪100.00 K‬ USD despite the estimated figure of ‪50.00 K‬ USD. In the next quarter revenue is expected to reach ‪50.00 K‬ USD.
Yes, you can track Edesa Biotech, Inc. financials in yearly and quarterly reports right on TradingView.
EDSA stock has fallen by 0.67% compared to the previous week, the month change is a 0.47% fall, over the last year Edesa Biotech, Inc. has showed a 38.26% decrease.
EDSA net income for the last quarter is ‪−1.68 M‬ USD, while the quarter before that showed ‪−1.72 M‬ USD of net income which accounts for 2.44% change. Track more Edesa Biotech, Inc. financial stats to get the full picture.
Today Edesa Biotech, Inc. has the market capitalization of ‪14.11 M‬, it has increased by 5.68% over the last week.
No, EDSA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, EDSA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Edesa Biotech, Inc. stock right from TradingView charts — choose your broker and connect to your account.
EDSA reached its all-time high on Aug 28, 2014 with the price of 6934.24 USD, and its all-time low was 2.46 USD and was reached on Oct 11, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 21, 2024, the company has 16.00 employees. See our rating of the largest employees — is Edesa Biotech, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Edesa Biotech, Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Edesa Biotech, Inc. stock shows the sell signal. See more of Edesa Biotech, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Edesa Biotech, Inc. future price: according to them, EDSA price has a max estimate of 32.00 USD and a min estimate of 19.00 USD. Read a more detailed Edesa Biotech, Inc. forecast: see what analysts think of Edesa Biotech, Inc. and suggest that you do with its stocks.